Patents by Inventor Hiren Pravinbhai PATEL

Hiren Pravinbhai PATEL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11865206
    Abstract: The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same.
    Type: Grant
    Filed: December 28, 2022
    Date of Patent: January 9, 2024
    Assignee: EMCURE PHARMACEUTICALS LTD
    Inventors: Sougata Pramanick, Aasiya Aslam Burhan, Mukund Keshav Gurjar, Hiren Pravinbhai Patel, Deepak Pragjibhai Gondaliya
  • Publication number: 20230210793
    Abstract: The present invention relates to a method for rapid infusion of carmustine, for example, in 30 minutes or 1 hour.
    Type: Application
    Filed: December 13, 2022
    Publication date: July 6, 2023
    Inventors: Deepak Pragjibhai GONDALIYA, Hiren Pravinbhai PATEL, Haresh Ishwarbhai PATEL, Mukund Keshav GURJAR
  • Publication number: 20230135144
    Abstract: The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same.
    Type: Application
    Filed: December 28, 2022
    Publication date: May 4, 2023
    Applicant: EMCURE PHARMACEUTICALS LTD
    Inventors: Sougata Pramanick, Aasiya Aslam Burhan, Mukund Keshav Gurjar, Hiren Pravinbhai Patel, Deepak Pragjibhai Gondaliya
  • Publication number: 20210361599
    Abstract: The present invention relates to a composition comprising nitrosourea and pharmaceutically acceptable excipients. In particular, the present invention relates to novel drug delivery systems of carmustine such as nano-suspension and micro-emulsion and its use for the treatment of cancer by intravenous administration. Also provided are methods for preparation of such novel drug delivery systems.
    Type: Application
    Filed: March 30, 2019
    Publication date: November 25, 2021
    Applicant: EMCURE PHARMACEUTICALS LIMITED
    Inventors: Deepak Pragjibhai Gondaliya, Hiren Pravinbhai Patel, Haresh Ishwarbhai Patel, Mukund Keshav Gurjar
  • Publication number: 20210322304
    Abstract: The present invention relates to a ready-to-use solution of carmustine that does not require dissolution or dilution of the carmustine prior to addition to saline and dextrose parenteral solutions. In particular, the invention relates to a stable liquid pharmaceutical composition containing carmustine in the form of ready-to-use solution and method for preparing the same.
    Type: Application
    Filed: September 3, 2019
    Publication date: October 21, 2021
    Applicant: EMCURE PHARMACEUTICALS LTD.
    Inventors: Sougata Pramanick, Aasiya Aslam Burhan, Mukund Keshav Gurjar, Hiren Pravinbhai Patel, Deepak Pragjibhai Gondaliya
  • Publication number: 20210038543
    Abstract: The present invention relates to an improved kit for preparing injectable carmustine solutions, methods of preparing and administering such solutions, and methods of treatment with such solutions. The kit includes a product vial containing lyophilised carmustine and a diluent vial containing an ethanol-free non-aqueous diluent. Reconstitution of the lyophilised carmustine in the ethanol-free non-aqueous diluent results in a carmustine solution with improved solubility and stability.
    Type: Application
    Filed: September 8, 2020
    Publication date: February 11, 2021
    Inventors: Deepak Pragjibhai Gondaliya, Hiren Pravinbhai Patel, Haresh Ishwarbhai Patel, Mukund Keshav Gurjar
  • Patent number: 10583101
    Abstract: The present invention relates to a pharmaceutical lipid composition comprising nitrosoureas and process for its preparation. In particular, the compositions of present invention are useful in the treatment of brain cancers having improved physicochemical and pharmacokinetic characteristics.
    Type: Grant
    Filed: November 22, 2017
    Date of Patent: March 10, 2020
    Assignee: EMCURE PHARMACEUTICALS LIMITED
    Inventors: Deepak Pragjibhai Gondaliya, Hiren Pravinbhai Patel, Arpan Suresh Chudasama, Neha Manubhai Patel, Mukund Keshav Gurjar
  • Publication number: 20190298671
    Abstract: The present invention relates to a pharmaceutical lipid composition comprising nitrosoureas and process for its preparation. In particular, the compositions of present invention are useful in the treatment of brain cancers having improved physicochemical and pharmacokinetic characteristics.
    Type: Application
    Filed: November 22, 2017
    Publication date: October 3, 2019
    Applicant: EMCURE PHARMACEUTICALS LIMITED
    Inventors: Deepak Pragjibhai Gondaliya, Hiren Pravinbhai Patel, Arpan Suresh Chudasama, Neha Manubhai Patel, Mukund Keshav Gurjar
  • Patent number: 10278946
    Abstract: The present invention relates to a stable liquid formulation of cabazitaxel. The formulation comprises cabazitaxel and at least one solubilizer. Typically, formulations are in the form of ready-to-use solutions or concentrates.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: May 7, 2019
    Assignee: EMCURE PHARMACEUTICALS LIMITED
    Inventors: Hiren Pravinbhai Patel, Haresh Ishwarbhai Patel, Arpan Suresh Chudasama, Neha Manubhai Patel, Deepak Pragjibhai Gondaliya, Mukund Keshav Gurjar, Samit Satish Mehta
  • Publication number: 20180311203
    Abstract: The present invention relates to a stable liquid formulation of cabazitaxel. The formulation comprises cabazitaxel, and at least one solubilizer. Typically, formulations are in the form of ready-to-use solutions or concentrates.
    Type: Application
    Filed: January 7, 2016
    Publication date: November 1, 2018
    Inventors: Hiren Pravinbhai PATEL, Haresh Ishwarbhai PATEL, Arpan Suresh CHUDASAMA, Neha Manubhai PATEL, Deepak Pragjibhai GONDALIYA, Mukund Keshav GURJAR, Samit Satish MEHTA
  • Publication number: 20180185323
    Abstract: The present invention relates to a stable liquid formulation of cabazitaxel. The formulation comprises cabazitaxel and at least one solubilizer. Typically, formulations are in the form of ready-to-use solutions or concentrates.
    Type: Application
    Filed: February 28, 2018
    Publication date: July 5, 2018
    Inventors: Hiren Pravinbhai PATEL, Haresh lshwarbhai PATEL, Arpan Suresh CHUDASAMA, Neha Manubhai PATEL, Deepak Pragjibhai GONDALIYA, Mukund Keshav GURJAR, Samit Satish MEHTA